Regeneron Investor
Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.
Technology:
Cell_Therapies, Others
Industry:
Biopharma, Biotechnology, Pharmaceutical
Headquarters:
Tarrytown, New York, United States
Zip:
NA
Founded Date:
1988-01-01
Employees Number:
5001-10000
Funding Status:
IPO
Number Of Exits:
3
Acquisitions Number:
Made Acquisitions
Investors Number:
1
Total Funding:
8900000
Estimated Revenue:
$1B to $10B
Last Funding Date:
2016-08-22
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership